Analyst Ratings January 26, 2026

Rothschild Redburn Elevates Meta to Buy, Cites Long-Term Upside Despite Rising Costs

Analyst raises price target to $900 while flagging higher FY26 spending and capex that could weigh on near-term EPS

By Sofia Navarro META
Rothschild Redburn Elevates Meta to Buy, Cites Long-Term Upside Despite Rising Costs
META

Rothschild Redburn upgraded Meta Platforms Inc. from Neutral to Buy and lifted its price target to $900 from $740, arguing that the stock's long-term upside outweighs short-term spending risks. The firm raised FY26 cost and capital-expenditure estimates, warning of an earnings headwind and a potential temporary dip in consensus EPS to roughly $27-28. Multiple other firms left ratings or targets mixed as Meta approaches its January 28 earnings report.

Key Points

  • Rothschild Redburn upgraded Meta from Neutral to Buy and raised its price target to $900 from $740, arguing long-term upside exceeds short-term spending risks.
  • The firm increased its FY26 total cost estimate to $158.6 billion and its FY26 capex projection to $117.1 billion, creating an estimated ~$2.75 EPS headwind versus consensus.
  • Other brokers offered mixed views ahead of the January 28 earnings report, with price targets ranging from $754 to $875 and commentary balancing AI-related caution with signs of revenue strength.

Rothschild Redburn moved to a Buy rating on Meta Platforms Inc. on Monday, increasing its price target to $900 from $740 while acknowledging material short-term cost pressures. At the time of the note, the social media company was trading at $658.76 and carried a market capitalization of $1.66 trillion. The company is scheduled to report fourth-quarter results in two days on January 28.

The research house said it recognizes near-term concerns tied to Meta’s escalating investment program. analysts at Rothschild Redburn observed that CEO Mark Zuckerberg appears to be operating in what they described as "founder mode," pursuing artificial-intelligence investments irrespective of immediate financial cost.

As a result, Rothschild Redburn raised its fiscal year 2026 total cost projection to $158.6 billion, which sits above the consensus estimate of $150.5 billion and buy-side expectations near $155.0 billion. The firm also increased its FY26 capital-expenditure forecast to $117.1 billion versus a consensus capex estimate of $110.0 billion.

Those higher cost and capex assumptions translate into a roughly $2.75 earning-per-share headwind relative to current consensus estimates, Rothschild Redburn calculated. The firm suggested that consensus FY26 EPS could temporarily fall to approximately $27-28 from the current $29.55 once fourth-quarter results are reflected - an adjustment that it said could push the stock lower toward the mid-$500s.

Despite those nearer-term stresses, Rothschild Redburn framed its upgrade around the disconnect it sees between prevailing share price levels and long-term intrinsic value. The firm concluded that at about $650 per share, Meta’s "upside potential far outweighs any near-term risks to the downside."


Other brokerages have issued a range of reactions ahead of the earnings release, underscoring a mix of optimism and caution across the sell side.

  • BofA Securities maintained its Buy rating and projects fourth-quarter revenue of $59.2 billion and earnings per share of $8.27, both noted as slightly above consensus.
  • Evercore ISI reiterated an Outperform rating and retains a $875 price target while projecting what it described as a "Modest Beat & Bracket Q4."
  • Raymond James trimmed its price target to $800, characterizing Meta’s AI transition as an "awkward phase," though it still forecasts revenue growth above consensus for 2026 and 2027.
  • Wells Fargo lowered its price target to $754 but kept an Overweight rating despite the $41 cut.
  • Stifel moved its target down to $785, expressing concerns about AI spending while also noting strong Instagram Reels performance in the fourth quarter.

The collective analyst commentary paints a picture of a major technology company balancing an aggressive AI investment program and elevated capital deployment against ongoing business strengths such as advertising and engagement on its platforms. As Meta approaches its next earnings release, the divergent price targets and ratings reflect differing views on how quickly those investments will translate into durable financial returns.

Given the range of forecasts, market participants will be watching both the near-term financial metrics and management commentary closely. Any adjustment to consensus EPS or new color on FY26 spending and capex could materially influence near-term stock moves, while the longer-term debate centers on whether current investments produce value that justifies higher valuations.

Risks

  • Higher-than-expected FY26 total costs and elevated capital expenditures could reduce EPS and weigh on share price in the near term - this impacts investors and the broader technology and capital-spending sectors.
  • Rothschild Redburn warns consensus FY26 EPS could fall to about $27-28 from $29.55 and that the stock might trade down to the mid-$500s, introducing market risk for equity holders and index compositions.
  • Analysts cite uncertainty in Meta’s AI transition - described by one firm as an "awkward phase" - creating execution risk for the company and potential volatility in advertising and digital media markets.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target Feb 2, 2026